Daniel Steinberg

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Seppo Ylä‐Herttuala, Wulf Palinski, Michael E. Rosenfeld et al. · Journal of Clinical Investigation · 1989 · 1.9K citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Low density lipoprotein undergoes oxidative modification in vivo.

Wulf Palinski, Michael E. Rosenfeld, Seppo Ylä‐Herttuala et al. · Proceedings of the National Academy of Sciences · 1989 · 1.5K citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

T E Carew, Dawn C. Schwenke, Daniel Steinberg · Proceedings of the National Academy of Sciences · 1987 · 1K citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Tore Henriksen, Eileen M. Mahoney, Daniel Steinberg · Proceedings of the National Academy of Sciences · 1981 · 1K citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Seppo Ylä‐Herttuala, Beth Lipton, Michael E. Rosenfeld et al. · Proceedings of the National Academy of Sciences · 1991 · 877 citations

Life Sciences, Cell Biology, Molecular Biology +11